Navigation Links
Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:10/31/2007

SAN FRANCISCO, Oct. 31 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, at 11:15 a.m. Eastern Time at the New York Palace Hotel.

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon(TM) for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

The Company reported results from its Phase 2 efficacy study of Dimebon in Alzheimer's disease in June 2007, showing that Dimebon improved the clinical course of patients by demonstrating meaningful improvement over placebo in each of the five disease aspects most important to patients, caregivers and physicians -- memory, thinking, activities of daily living, behavior and overall function. Significant gains in these disease aspects were evident as early as the twelfth week of treatment. After six months of treatment, patients were significantly better off than they were at the start of therapy on all key aspects of the disease. Dimebon's overall benefit compared to placebo continued to increase over time and was greater at 12 months that at six months.

A live audio webcast of the presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical develo
'/>"/>

SOURCE Medivation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...2008 - Book signing to follow his presentation, W...environment, elements of the global marketplace, a...Tech Conference., Wednesday panel presentations w...ry with the wireless & IT sectors, remote patient ...er when entering M&A transactions,China,s health c...
...Florida researcher may have found a defense agains...rd of Europe,s population in the Middle Ages and w...hreat today. , UCF Professor Henry Daniell and h...ch shows is highly effective against the plague. F...SDA funded research appear in the August edition o...
..., 2008 -- A new interactive web lesson teaches upp...nts how herbicides are developed. The lesson, deve..., has the seal of approval by the Journal of Natu...published in the 2008 issue. , Surprisingly, almo...discovered by random searching. Collections of che...
Other Biology Technology:Former Speaker of the House Newt Gingrich Featured Wednesday 2UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 1 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 2 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 3Key Protein Might Shield Brain Cells 51813 1Hard To Treat Diseases 28HTDS PK 29 Tender Order To Indonesia 51808 1Hard To Treat Diseases 28HTDS PK 29 Tender Order To Indonesia 51808 2
...) The February edition of the Journal of Nutriti... between infant feeding and health outcomes relate....D., professor of clinical epidemiology at the Uni...vascular in the Department of Medicine at the Oreg...thors of the report, "A longer period of breastfee...
... a mathematical model of the mating game to help e...y, by researchers at UCL (University College Londo...f Economics and Political Science), shows that ext...bility to a female and enables the female to scree...he research, published this month in the Journal ...
...disease nephropathia epidemica (NE) has been linke...tter summers, milder winters and increased seedcro...d in BioMed Central,s open access International J...his rodent-borne disease to known effects of globa...f Microbiology & Immunology at Belgium,s Rega Inst...
Other Biology News:New infant feeding and obesity research adds insight to ongoing issue 2Why you can't hurry love 2Why you can't hurry love 3Global warming linked to European viral epidemic 2
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
...29 cm, 1. One system for gel staining and blot pr...ilver-stain gels for proteins and nucleic acid ana...ection and chromogenic detection. Programmable con... time.Proven design for consistent, high-quality p...
...SDA Research Registered OLAW Assured AAALAC Accred...LAS Certified Technicians Documentation GLP Proc...est Focus CRP is your one stop shopping point fo...fer free project consultation, free peptide sequen...
..., FHS-LVF, and the CVD-Diffuse We've combined our...ilters to create the world's first notch filter wi...bandpass. Each filter features an excellent transm...se filters -- with interference coatings applied t...
Biology Products: